Does off-pump CABG reduce the composite outcome of death, stroke, myocardial infarction, repeat revascularization, or new renal-replacement therapy compared to on-pump CABG in patients 75 years of age or older?
In elderly patients (≥75 years), off-pump CABG does not significantly reduce the composite of death, stroke, MI, repeat revascularization, or new renal-replacement therapy compared to on-pump CABG at up to 12 months.
In patients 75 years of age or older, there was no significant difference between on-pump and off-pump CABG with regard to the composite outcome of death, stroke, myocardial infarction, repeat revascularization, or new renal-replacement therapy within 30 days and within 12 months after surgery. (Funded by Maquet; GOPCABE ClinicalTrials.gov number, NCT00719667.).
Diegeler et al. (Mon,) studied this question.